Emma Hockly - Concepedia

Author

Emma Hockly

King's College London

Also Known As

E Hockly, E. Hockly, EMMA HOCKLY, Emma Hockly

Publications

Citations

H-Index

Concepts

All Affiliations

King's College London Guy's Hospital Emory University University of Exeter King's College School

About

Emma Hockly is an author at King's College London specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	902
2	Health Sciences	1	1	137
3	Social Sciences	1	1	70
4	Biology	1	1	331
5	Cell Biology	1	1	125

Emma Hockly

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease Emma Hockly, Victoria M. Richon, Benjamin Woodman, Proceedings of the National Academy of Sciences	2003	836
Environmental enrichment slows disease progression in R6/2 Huntington's disease mice Emma Hockly, Patricia M. Cordery, Benjamin Woodman, Annals of Neurology GeneticsNeurochemical BiomarkersEnvironmental EnrichmentAlzheimer's DiseaseDegenerative Pathology	2002	331
Minocycline and doxycycline are not beneficial in a model of Huntington's disease Donna L. Smith, Benjamin Woodman, Amarbirpal Mahal, Annals of Neurology	2003	169
The HdhQ150/Q150 knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes Ben Woodman, Rachel Butler, Christian Landles, Brain Research Bulletin Knockout MouseGenetic DisorderGeneticsGenomic MechanismMolecular Biology	2006	165
Standardization and statistical approaches to therapeutic trials in the R6/2 mouse Emma Hockly, Benjamin Woodman, Amarbirpal Mahal, Brain Research Bulletin Knockout MousePreclinical Drug EvaluationStatistical ApproachesMedicineClinical Trials	2003	137
Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease Caroline Benn, Christian Landles, Li He, Human Molecular Genetics GeneticsGenomic MechanismEpigeneticsNeurological PhenotypesExon 1	2005	125
Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's disease Emma Hockly, Jamie Tse, Amy L. Barker, Neurobiology of Disease Medicinal ChemistryMedicinePsychotropic MedicationExperimental TherapeuticNeuropharmacology	2005	74
Inhibition of Polyglutamine Aggregation in R6/2 HD Brain Slices—Complex Dose–Response Profiles Donna L. Smith, R Portier, Ben Woodman, Neurobiology of Disease NeurophysiologyMedicinePolyglutamine AggregationPsychopharmacologyNeuropharmacology	2001	70

Page 1